Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1

Carcinogenesis

Volumn 34, Issue 3, 2013, Pages 647-657

  Kumar, Rahul ^a,b   Alam, Shamshad ^a   Chaudhari, Bhushan P ^a   Dwivedi, Premendra D ^a   Jain, Swatantra K ^b   Ansari, Kausar M ^a   Das, Mukul ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[ALPHA]ANTHRACENE; ANTHRACENE DERIVATIVE; CYCLIN D1; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OCHRATOXIN; PROTEIN C FOS; PROTEIN C JUN; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYCLIN D1; CYCLOOXYGENASE 2; ENZYME ACTIVATION; EPIDERMIS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HYPERPLASIA; KERATINOCYTES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OCHRATOXINS; ORNITHINE DECARBOXYLASE; PHOSPHORYLATION; PRIMARY CELL CULTURE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, SMALL INTERFERING; SKIN NEOPLASMS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION;

EID: 84874789152     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs368     Document Type: Article

References (55)

1. Council of Agricultural Science and Technology. (2003) Mycotoxins: Risks in Plant, Animal, and Human Systems. Task Force Report No. 139. Council of Agricultural Science and Technology, Ames, IA.
2. Vrabcheva, T. et al. (2000) Co-occurrence of ochratoxin A and citrinin in cereals from Bulgarian villages with a history of Balkan endemic nephropathy. J. Agric. Food Chem., 48, 2483-2488.
3. Kuiper-Goodman, T. et al. (1989) Risk assessment of the mycotoxin ochratoxin A. Biomed. Environ. Sci., 2, 179-248.
4. O'Brien, E. et al. (2005) Ochratoxin A: the continuing enigma. Crit. Rev. Toxicol., 35, 33-60.
5. Fink-Gremmels, J. (2005) Conclusions from the workshops on ochratoxin A in food: recent developments and significance, organized by ILSI Europe in Baden (Austria), 29 June-1 July 2005. Food Addit. Contam., 22 (suppl. 1), 1-5.
6. Pfohl-Leszkowicz, A. et al. (2012) An update on direct genotoxicity as a molecular mechanism of ochratoxin A carcinogenicity. Chem. Res. Toxicol., 25, 252-262.
7. Mally, A. et al. (2005) DNA adduct formation by ochratoxin A: review of the available evidence. Food Addit. Contam., 22 (suppl. 1), 65-74.
8. Pfohl-Leszkowicz, A. et al. (2007) Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res., 51, 61-99.
9. Rached, E. et al. (2007) Ochratoxin A: 13-week oral toxicity and cell proliferation in male F344/N rats. Toxicol. Sci., 97, 288-298.
10. Marin-Kuan, M. et al. (2007) MAPK-ERK activation in kidney of male rats chronically fed ochratoxin A at a dose causing a significant incidence of renal carcinoma. Toxicol. Appl. Pharmacol., 224, 174-181.
11. Rumora, L. et al. (2009) A journey through mitogen-activated protein kinase and ochratoxin A interactions. Arh. Hig. Rada Toksikol., 60, 449-456.
12. Poirier, M.C. (2004) Chemical-induced DNA damage and human cancer risk. Nat. Rev. Cancer, 4, 630-637.
13. Rundhaug, J.E. et al. (2010) Molecular mechanisms of mouse skin tumor promotion. Cancers, 2, 436-482.
14. Abel, E.L. et al. (2009) Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat. Protocol., 4, 1350-1362.
15. FAO. (1990) Food and Nutrition Paper 14/10, Manual of Food Quality Control 10. Training in Mycotoxin Analysis. Food and Agriculture Organization of the United Nations, Rome, pp. 4-10.
16. WHO. (1998) Food Additives Series: No. 884, Evaluation of certain food additives and contaminants. Prepared by 49th meeting of JECFA. Geneva, pp. 357-468.
17. Peraica, M. et al. (1999) Toxic effects of mycotoxins in humans. Bull. World Health Organ., 77, 754-766.
18. Boonen, J. et al. (2012) Human skin penetration of selected model mycotoxins. Toxicology, 301, 21-32.
19. Mayer, S. et al. (2007) The significance of mycotoxins in the framework of assessing workplace-related hazards. Gefahrstoffe Reinhalt Luft, 67, 407-417.
20. Degen, G.H. (2011) Tools for investigating workplace-related risks from mycotoxin exposure. World Mycotoxin J., 4, 315-327.
21. Pohland, A.E. et al. (1992) Ochratoxin A: a review. Pure Appl. Chem., 64, 1029-1045.
22. Kumar, R. et al. (2012) Topical application of ochratoxin A causes DNA damage and tumor initiation in mouse skin. PLoS ONE, 7, e47280.
23. Verma, A.K. et al. (1979) Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion. Cancer Res., 39, 419-425.
24. Gupta, K.P. et al. (1992) Status of ornithine decarboxylase activity and DNA synthesis in mancozeb-exposed mouse skin. Carcinogenesis, 13, 131-133.
25. Yadav, A. et al. (2012) In vitro studies on immunotoxic potential of Orange II in splenocytes. Toxicol. Lett., 208, 239-245.
26. Kumar, R. et al. (2012) Detection of ochratoxin A in wheat samples in different regions of India. Food Control, 26, 63-67.
27. Yuspa, S.H. et al. (1974) Altered differentiation of mouse epidermal cells treated with retinyl acetate in vitro. Exp. Cell Res., 86, 95-105.
28. Fautrel, A. et al. (1991) A multicentre study of acute in vitro cytotoxicity in rat liver cells. Toxicol. In Vitro, 5, 543-547.
29. Saxena, N. et al. (2011) Role of mitogen activated protein kinases in skin tumorigenicity of patulin. Toxicol. Appl. Pharmacol., 257, 264-271.
30. Rundhaug, J.E. et al. (2010) Molecular mechanisms of mouse skin tumor promotion. Cancers, 2, 436-482.
31. Slaga, T.J. et al. (1980) Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion. Proc. Natl. Acad. Sci. U.S.A., 77, 3659-3663.
32. O'Brien, T.G. (1976) The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis. Cancer Res., 36, 2644-2653.
33. Halmekytö, M. et al. (1992) Enhanced papilloma formation in response to skin tumor promotion in transgenic mice overexpressing the human ornithine decarboxylase gene. Biochem. Biophys. Res. Commun., 187, 493-497.
34. Hull, M.A. (2005) Cyclooxygenase-2: how good is it as a target for cancer chemoprevention? Eur. J. Cancer, 41, 1854-1863.
35. Robles, A.I. et al. (1995) Early overexpression of cyclin D1 protein in mouse skin carcinogenesis. Carcinogenesis, 16, 781-786.
36. Martinez, L.A. et al. (2000) Deregulated expression of cyclin D1 overrides antimitogenic signals. Oncogene, 19, 315-322.
37. Ansari, K.M. et al. (2008) Multiple signaling pathways are responsible for prostaglandin E2-induced murine keratinocyte proliferation. Mol. Cancer Res., 6, 1003-1016.
38. Robles, A.I. et al. (1998) Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo. Genes Dev., 12, 2469-2474.
39. Tiano, H.F. et al. (2002) Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res., 62, 3395-3401.
40. Chen, N. et al. (2001) Transactivation of the epidermal growth factor receptor is involved in 12-O-tetradecanoylphorbol-13-acetate-induced signal transduction. J. Biol. Chem., 276, 46722-46728.
41. Segrelles, C. et al. (2002) Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene, 21, 53-64.
42. Dhillon, A.S. et al. (2007) MAP kinase signalling pathways in cancer. Oncogene, 26, 3279-3290.
43. Porter, A.C. et al. (1998) Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene, 16, 1343-1352.
44. Zhang, W. et al. (2002) MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res., 12, 9-18.
45. Johnson, G.L. et al. (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science, 298, 1911-1912.
46. Engelberg, D. (2004) Stress-activated protein kinases-tumor suppressors or tumor initiators? Semin. Cancer Biol., 14, 271-282.
47. Lee, J.C. et al. (2007) Humulone inhibits phorbol ester-induced COX-2 expression in mouse skin by blocking activation of NF-κB and AP-1: IκB kinase as respective potential upstream targets. Carcinogenesis, 28, 1491-1498.
48. Adams, P.D. et al. (1991) TPA-induced activation of MAP kinase. FEBS Lett., 290, 77-82.
49. Bourcier, C. et al. (2006) p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1)-dependent signaling contributes to epithelial skin carcinogenesis. Cancer Res., 66, 2700-2707.
50. Schindler, E.M. et al. (2009) p38δ mitogen-activated protein kinase is essential for skin tumor development in mice. Cancer Res., 69, 4648-4655.
51. Chen, N. et al. (2001) Suppression of skin tumorigenesis in c-Jun NH2-terminal kinase-2-deficient mice. Cancer Res., 61, 3908-3912.
52. Karin, M. et al. (1997) AP-1 function and regulation. Curr. Opin. Cell Biol., 9, 240-246.
53. Gilmore, T.D. (2006) Introduction to NF-kappaB: players, pathways, perspectives. Oncogene, 25, 6680-6684.
54. Surh, Y.J. et al. (2005) Signal transduction network leading to COX-2 induction: a road map in search of cancer chemopreventives. Arch. Pharm. Res., 28, 1-15.
55. Budunova, I.V. et al. (1999) Increased expression of p50-NF-κB and constitutive activation of NF-nB transcription factors during mouse skin carcinogenesis. Oncogene, 18, 7423-7431.